Compounds > nelfinavir
Page last updated: 2024-08-24

nelfinavir and Adverse Drug Event

nelfinavir has been researched along with Adverse Drug Event in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Müller, L; Singer, T1

Other Studies

3 other study(ies) available for nelfinavir and Adverse Drug Event

ArticleYear
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
    PLoS computational biology, 2011, Volume: 7, Issue:12

    Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests

2011
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
EMS in Viracept--the course of events in 2007 and 2008 from the non-clinical safety point of view.
    Toxicology letters, 2009, Nov-12, Volume: 190, Issue:3

    Topics: Adult; Animals; Dose-Response Relationship, Drug; Drug and Narcotic Control; Drug Contamination; Drug-Related Side Effects and Adverse Reactions; Ethyl Methanesulfonate; European Union; Female; History, 21st Century; HIV Protease Inhibitors; Humans; Mice; Mutagenicity Tests; Mutagens; Nelfinavir; No-Observed-Adverse-Effect Level; Pregnancy; Product Surveillance, Postmarketing; Rats; Registries; Risk Assessment

2009